Abstract

A number of factors must be taken into consideration when comparing the relative efficacy of macrolides-lincosamides-streptogramins (MLS) in staphylococcal infections: these include their antibacterial activity, their pharmacokinetic characteristics, their tolerance, and the results achieved in clinical practice.

This content is only available as a PDF.
You do not currently have access to this article.